BioVie Inc. cash flow to debt ratio of -5.44K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

BioVie Inc.'s free cash flow has increased -31.92% from $-27.95M last year to $-19.03M, signaling increasing performance

BioVie Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability.

BioVie Inc.'s debt has decreased relative to shareholder equity from 0.39 last year to 0.02 today, signaling strengthened financials

BioVie Inc. has a net cash position, so leverage is healthy.

BioVie Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

BioVie Inc. has insufficient data to evaluate this check.

BioVie Inc.'s short-term assets of $20.70M exceed its short-term liabilities of $2.27M

BioVie Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

BioVie Inc.'s return on equity of -101.09%, is lower than 15.00%, indicating bad performance

BioVie Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

BioVie Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

BioVie Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

BioVie Inc. has negative free cash flow, indicating cash burn

BioVie Inc.'s yearly earnings has increased -45.39% since last year from $-32.12M to $-17.54M, signaling increasing performance

BioVie Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -129.50% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

BioVie Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

BioVie Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

BioVie Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

BioVie Inc. has insufficient data to evaluate this check.

BioVie Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

BioVie Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

BioVie Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

BioVie Inc. has insufficient data to evaluate this check.

BioVie Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

BioVie Inc. has a price-to-book ratio of 0.53x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

BioVie Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue